Table 2.
Description of sample enrolled in SAFETY treatment development trial (N=35).
| Mean or Frequency | SD or % | |
|---|---|---|
| Age, in years | 14.89 | 1.60 |
| Gender) | ||
| Male | 5 | 14% |
| Female | 30 | 86% |
| Race, % (N)* | ||
| White | 14 | 40% |
| Hispanic | 12 | 34% |
| African American | 4 | 11% |
| Asian-Other | 5 | 14% |
| Emergency Department Visit for Suicidal Behavior | 34 | 97% |
| Inpatient Hospitalization | 30 | 86% |
| Number of Lifetime Suicide
Attempts 1 2 3 4 5 |
19 6 6 1 3 |
54% 17% 17% 3% 9% |
| Nonsuicidal Self-Injurious Behavior (NSSI) | 20 | 57% |
| Youth, Major Depressive Disorder (MDD, DISC) Total MDD + Intermediate MDD |
16 25 |
40 % 63 % |
| Severe Depressive Symptoms, CES-D ≥ 24 | 20 | 50 % |
| DUSI, Problematic Substance Use | 20 | 57% |
| CBCL Externalizing, Clinical Range | 12 | 34% |
| CBCL Internalizing, Clinical Range | 16 | 46% |
| CBCL Total Problem Behavior, Clinical Range | 18 | 51% |
Note: NSSI= Nonsuicidal Self-Injury, MDD=Major Depressive Disorder, DISC=Diagnostic Interview Schedule for Children, CES-D=Center for Epidemiological Studies-Depression Scale, DUSI=Drug Use Screening Inventory, problematic use defined as endorsed some substance use related impairment, CBCL=Child Behavior Checklist